Xufeng Lu

463 total citations · 1 hit paper
15 papers, 329 citations indexed

About

Xufeng Lu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Xufeng Lu has authored 15 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Xufeng Lu's work include Nanoplatforms for cancer theranostics (4 papers), Liver physiology and pathology (3 papers) and MicroRNA in disease regulation (3 papers). Xufeng Lu is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Liver physiology and pathology (3 papers) and MicroRNA in disease regulation (3 papers). Xufeng Lu collaborates with scholars based in China, United States and Nepal. Xufeng Lu's co-authors include Hong Bu, Yongjie Zhou, Yujun Shi, Hongjie Ji, Yongjie Zhu, Xiaoyue Cao, Zhenru Wu, Xiang Zhuang, Qing Xu and Yong Zeng and has published in prestigious journals such as Journal of Hepatology, Advanced Science and eLife.

In The Last Decade

Xufeng Lu

15 papers receiving 328 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy

2024 93 citations Xufeng Lu, Xiaohong Chen et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xufeng Lu China	8	151	68	63	47	45	15	329
Yuchen Hou China	12	187 1.2×	102 1.5×	55 0.9×	32 0.7×	26 0.6×	21	311
Zhu Wang China	8	141 0.9×	70 1.0×	51 0.8×	46 1.0×	20 0.4×	20	274
Johan Swinnen Belgium	7	131 0.9×	107 1.6×	33 0.5×	47 1.0×	34 0.8×	16	330
Liang Feng China	13	86 0.6×	45 0.7×	52 0.8×	144 3.1×	59 1.3×	16	384
Fubo Zhou China	5	148 1.0×	72 1.1×	41 0.7×	83 1.8×	83 1.8×	6	323
Kelly Koral United States	10	109 0.7×	25 0.4×	49 0.8×	46 1.0×	47 1.0×	15	325
Tzu‐I Chao Taiwan	9	197 1.3×	87 1.3×	46 0.7×	107 2.3×	57 1.3×	10	475
Hélène Dubois‐Pot‐Schneider France	8	191 1.3×	81 1.2×	46 0.7×	68 1.4×	139 3.1×	16	432
Romina Rajabi Iran	8	171 1.1×	91 1.3×	54 0.9×	39 0.8×	12 0.3×	9	307

Countries citing papers authored by Xufeng Lu

Since Specialization

Citations

This map shows the geographic impact of Xufeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufeng Lu more than expected).

Fields of papers citing papers by Xufeng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufeng Lu. The network helps show where Xufeng Lu may publish in the future.

Co-authorship network of co-authors of Xufeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xufeng Lu. A scholar is included among the top collaborators of Xufeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufeng Lu. Xufeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Deng, Wenhai, Shuaibin Wang, Yongyong Lu, et al.. (2025). Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer. International Journal of Biological Macromolecules. 310(Pt 3). 143265–143265. 2 indexed citations

Zheng, Zhikun, Yizhou Xu, Wenhai Deng, et al.. (2025). An Fe(III)-covalent organic framework (COF)–sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy. Materials Today Bio. 34. 102135–102135. 4 indexed citations

Lin, Ji, Yin Jin, Qiantong Dong, et al.. (2025). NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer. eLife. 13. 1 indexed citations

Lu, Xufeng, Wenhai Deng, Shuaibin Wang, et al.. (2024). PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy. Materials Today Bio. 29. 101317–101317. 13 indexed citations

Lu, Xufeng, Xiaohong Chen, Yongdong Yi, et al.. (2024). Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy. Advanced Science. 11(18). e2309984–e2309984. 93 indexed citations breakdown →

Jiang, Hao, Yiwei Jiang, Weiteng Zhang, et al.. (2023). Machine Learning Radiomics Liver Function Model for Prognostic Prediction After Radical Resection of Advanced Gastric Cancer: A Retrospective Study. Annals of Surgical Oncology. 31(3). 1749–1759. 6 indexed citations

Lu, Xufeng, Xiaoyue Cao, Yongjie Zhu, et al.. (2018). Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway. Cell Death and Disease. 9(3). 398–398. 123 indexed citations

Cao, Xiaoyue, Hongjie Ji, Yongjie Zhou, et al.. (2017). Elevated expression of G s α in intrahepatic cholangiocarcinoma associates with poor prognosis. Hepatobiliary & pancreatic diseases international. 16(6). 638–644. 4 indexed citations

Wu, Zhenru, Xufeng Lu, Hongjie Ji, et al.. (2017). Clinical significance of expression of histone deacetylase 3 in hepatocellular carcinoma. World Chinese Journal of Digestology. 25(10). 922–922. 1 indexed citations

10.

Zhou, Yongjie, Lei Zhang, Hongjie Ji, et al.. (2016). MiR‐17~92 ablation impairs liver regeneration in an estrogen‐dependent manner. Journal of Cellular and Molecular Medicine. 20(5). 939–948. 17 indexed citations

11.

Lu, Changli, Jie Xia, Yongjie Zhou, et al.. (2015). Loss of Gsα impairs liver regeneration through a defect in the crosstalk between cAMP and growth factor signaling. Journal of Hepatology. 64(2). 342–351. 22 indexed citations

12.

Lu, Xufeng. (2015). Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation. World Journal of Gastroenterology. 21(21). 6591–6591. 8 indexed citations

13.

Lu, Changli, Yan Qiu, Xufeng Lu, Gan‐di Li, & Hong Bu. (2015). Synchronous diffuse ganglioneuromatosis and multiple schwannomas of the colon: A case report and literature review. Experimental and Therapeutic Medicine. 9(3). 733–736. 7 indexed citations

14.

Du, Zhenggui, Yongjie Zhou, Xufeng Lu, et al.. (2015). Octreotide prevents liver failure through upregulating 5′‐methylthioadenosine in extended hepatectomized rats. Liver International. 36(2). 212–222. 19 indexed citations

15.

Leffert, Hyam L., Katherine S. Koch, Xufeng Lu, et al.. (1990). Cellular and molecular biology of hepatocyte growth, regeneration and gene expression.. PubMed. 24. 352–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact